Replies to post #216205 on Biotech Values

[DewDiligence]

ELOX -24% on purportedly-positive phase-2 CF data:

https://www.globenewswire.com/news-release/2021/11/17/2336222/0/en/Eloxx-Pharmaceuticals-Reports-Positive-Topline-Results-from-Monotherapy-Arms-of-Phase-2-Clinical-Trial-of-ELX-02-in-Class-1-Cystic-Fibrosis-Patients.html